Carrier-mediated transport of H1-antagonist at the blood-brain barrier: a common transport system of H1-antagonists and lipophilic basic drugs

Pharm Res. 1994 Nov;11(11):1516-8. doi: 10.1023/a:1018980914687.

Abstract

The blood-brain barrier (BBB) transport system for H1-antagonists was studied using primary cultured bovine brain capillary endothelial cells (BCEC). The uptake of [3H]mepyramine was inhibited by various H1-antagonists. Ketotifen competitively inhibited [3H]mepyramine uptake with an inhibition constant (Ki) of 46.8 microM. Lipophilic basic drugs such as propranolol, lidocaine and imipramine significantly inhibited [3H]mepyramine uptake. In particular, propranolol inhibited [3H]mepyramine uptake competitively at an inhibition constant (Ki) of 51.1 microM. Moreover, in ATP-depleted BCEC, [3H]mepyramine uptake was stimulated by preloading with H1-antagonists and lipophilic basic drugs. These results indicated that H1-antagonists are transported across the BBB via a carrier-mediated transport system common to lipophilic basic drugs.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Blood-Brain Barrier / physiology*
  • Carrier Proteins / physiology*
  • Cattle
  • Cells, Cultured
  • Endothelium, Vascular / metabolism
  • Histamine H1 Antagonists / pharmacokinetics*
  • Imipramine / pharmacokinetics
  • Lidocaine / pharmacokinetics
  • Propranolol / pharmacokinetics
  • Pyrilamine / pharmacokinetics*
  • Solubility

Substances

  • Carrier Proteins
  • Histamine H1 Antagonists
  • Lidocaine
  • Propranolol
  • Pyrilamine
  • Imipramine